WA
ABMD

WestEnd Advisors’s Abiomed Inc ABMD Stock Holding History

WestEnd Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1
Closed – – 323
2022
Q3 		$0 Hold
1
– – ﹤0.01% 348
2022
Q2 		$247 Buy
+1
New +$270 ﹤0.01% 189

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

WestEnd Advisors's ABMD Position: Q4 2022 in Review

WestEnd Advisors sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1 share.

WestEnd Advisors first reported a position in ABMD in Q2 2022 and held it in 2 quarters. The position peaked at $247 in Q2 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • WestEnd Advisors reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • WestEnd Advisors sold 1 Abiomed Inc share in Q4 2022.
  • WestEnd Advisors first reported a position in Abiomed Inc in Q2 2022 and held it in 2 quarters.
  • WestEnd Advisors's Abiomed Inc position peaked at $247 in Q2 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on WestEnd Advisors's 13F filing for Q4 2022, filed 31 Jan 2023.